Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 4 min ago
Peer-reviewedCC BY-NC-ND 4.0JACC: Basic to Translational Science

Obesity and Diabetes Increase SARS-CoV-2 Susceptibility Through Angiotensin-Converting Enzyme 2, Immunologic, and Gut Microbial Dysregulation

20 more authors
21 affiliations
  1. 1Department of Physiology, University of Alberta, Edmonton, Alberta, Canada
  2. 2Division of Cardiology, Department of Medicine, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada
  3. 3Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada
  4. 4Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada
  5. 5Department of Cell Biology, University of Alberta, Edmonton, Alberta, Canada
  6. 6Poultry Diseases Department, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt
  7. 7Department of Laboratory Medicine and Pathology, University of Alberta Hospital, Edmonton, Alberta, Canada
  8. 8Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
  9. 9Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada
  10. 10Pathology Unit, National Institute for Infectious Diseases “Lazzaro Spallanzani”, IRCCS, Rome, Italy
  11. 11Scientific Direction, National Institute for Infectious Diseases “Lazzaro Spallanzani”, IRCCS, Rome, Italy
  12. 12Cardiovascular Pathology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy
  13. 13Center for Immunity, Inflammation and Infectious Diseases, Montreal Clinical Research Institute (IRCM), Montreal, Quebec, Canada
  14. 14Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
  15. 15Division of Nephrology, Department of Medicine, University Health Network, Toronto, Ontario, Canada
  16. 16Department of Pathology, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
  17. 17Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama, USA
  18. 18Wright Labs, LLC, Huntingdon, Pennsylvania, USA
  19. 19Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montreal, Quebec, Canada
  20. 20Helmholtz Centre for Infection Research, Braunschweig, Germany
  21. 21University of Vienna, Vienna, Austria

Abstract

Angiotensin-converting enzyme 2 (ACE2), the receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is ubiquitously expressed and contributes to cardiovascular, metabolic, and gastrointestinal homeostasis. In this study, we observed ACE2 loss in organs of patients with COVID-19 and in SARS-CoV-2-infected cells. In aged, obese, and diabetic mice, SARS-CoV-2 infection caused greater morbidity, persistent pulmonary infection, intestinal and metabolic disruption, and impaired cardiac Wnt and interferon-γ signaling. ACE2-deficient obese-diabetic mice showed cardiovascular, intestinal, metabolic, and neurobehavioral abnormalities, providing a complementary model to examine ACE2-associated disruption in metabolic disease. Exploratory metabolic profiling identified shared disruptions in taurine, tryptophan, and microbiota-derived metabolites across clinical and preclinical samples. These findings identify metabolic disease as a modifier of SARS-CoV-2 susceptibility and support ACE2-associated dysregulation as one contributor to selected infection-related sequelae.

Related

  1. Angiotensin-Converting Enzyme in Patients With Early-Stage Psychosis
    Kun Yang, Luisa Longo, Pasquale Di Carlo +11
    JAMA PsychiatryPeer-reviewedLicence not statedFull text2 citedPsychiatry & mental healthPMC
  2. Case-control study on the association of angiotensin-converting enzyme gene I/D rs4646944 single nucleotide polymorphism and young-onset cryptogenic ischemic stroke in an Algerian cohort Estudo de caso-controle sobre associação do polimorfismo de nucleotídeo único I/D rs4646944 do gene da enzima conversora de angiotensina e acidente vascular isquêmico criptogênico de início precoce em coorte argelina
    Mohamed Lebsir, Mohamed Larbi Rezgoun, Boubekeur Saddik Fekraoui +4
    Jornal vascular brasileiroPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Vascular Remodelling in Idiopathic Nephrotic Syndrome with Administration of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
    H. Dimiati, S. Haris, K. Hasballah +1
    medRxivPreprintCC BYFull textGeneral medicinemedRxiv
  4. Glioblastoma model mouse rescue from mortality by brain-targeted catalytically-enhanced angiotensin-converting enzyme 2 mutant-antibody fusion protein
    P. Heinzelman, G. R. Nageeb, J. Choi +4
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  5. In vitro inhibition of α-amylase and angiotensin converting enzyme by fava bean (Vicia faba) protein-derived peptides, as revealed by kinetics, molecular docking and molecular dynamics
    Timilehin David Oluwajuyitan, Toluwase Hezekiah Fatoki, Stanley Chukwuejim +2
    Food Production, Processing and NutritionPeer-reviewedCC BY-NC-ND 4.0Full textNutritionPMCEurope PMCDOAJ
BibTeX
@article{gheblawi2026obesity,
  title = {{Obesity and Diabetes Increase SARS-CoV-2 Susceptibility Through Angiotensin-Converting Enzyme 2, Immunologic, and Gut Microbial Dysregulation}},
  author = {Mahmoud Gheblawi and Mobin Khoramjoo and Mohamed Elaish and Kaiming Wang and Lakshmi Puttagunta and Faqi Wang and Pavel Zhabyeyev and Natacha S. Ogando and Ratnadeep Basu and Anran Zhang and Colombo Daniele and Franca Del Nonno and Enrico Girardi and Monica De Gaspari and Cristina Basso and Brian Chiu and Kodjovi D. Mlaga and Rohan John and James W. Scholey and Qiumin Tan and Ram Prasad and Justin R. Wright and Regina Lamendella and Christopher Power and David H. Evans and Emilia Liana Falcone and Ryan S. Noyce and Josef M. Penninger and Zamaneh Kassiri and Tom C. Hobman and Maria B. Grant and Gavin Y. Oudit},
  journal = {JACC: Basic to Translational Science},
  year = {2026},
  month = oct,
  doi = {10.1016/j.jacbts.2026.101691},
  url = {https://doi.org/10.1016/j.jacbts.2026.101691},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Obesity and Diabetes Increase SARS-CoV-2 Susceptibility Through Angiotensin-Converting Enzyme 2, Immunologic, and Gut Microbial Dysregulation
AU  - Mahmoud Gheblawi
AU  - Mobin Khoramjoo
AU  - Mohamed Elaish
AU  - Kaiming Wang
AU  - Lakshmi Puttagunta
AU  - Faqi Wang
AU  - Pavel Zhabyeyev
AU  - Natacha S. Ogando
AU  - Ratnadeep Basu
AU  - Anran Zhang
AU  - Colombo Daniele
AU  - Franca Del Nonno
AU  - Enrico Girardi
AU  - Monica De Gaspari
AU  - Cristina Basso
AU  - Brian Chiu
AU  - Kodjovi D. Mlaga
AU  - Rohan John
AU  - James W. Scholey
AU  - Qiumin Tan
AU  - Ram Prasad
AU  - Justin R. Wright
AU  - Regina Lamendella
AU  - Christopher Power
AU  - David H. Evans
AU  - Emilia Liana Falcone
AU  - Ryan S. Noyce
AU  - Josef M. Penninger
AU  - Zamaneh Kassiri
AU  - Tom C. Hobman
AU  - Maria B. Grant
AU  - Gavin Y. Oudit
PY  - 2026
DA  - 2026/10/26
JO  - JACC: Basic to Translational Science
DO  - 10.1016/j.jacbts.2026.101691
UR  - https://doi.org/10.1016/j.jacbts.2026.101691
AB  - Angiotensin-converting enzyme 2 (ACE2), the receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is ubiquitously expressed and contributes to cardiovascular, metabolic, and gastrointestinal homeostasis. In this study, we observed ACE2 loss in organs of patients with COVID-19 and in SARS-CoV-2-infected cells. In aged, obese, and diabetic mice, SARS-CoV-2 infection caused greater morbidity, persistent pulmonary infection, intestinal and metabolic disruption, and impaired cardiac Wnt and interferon-γ signaling. ACE2-deficient obese-diabetic mice showed cardiovascular, intestinal, metabolic, and neurobehavioral abnormalities, providing a complementary model to examine ACE2-associated disruption in metabolic disease. Exploratory metabolic profiling identified shared disruptions in taurine, tryptophan, and microbiota-derived metabolites across clinical and preclinical samples. These findings identify metabolic disease as a modifier of SARS-CoV-2 susceptibility and support ACE2-associated dysregulation as one contributor to selected infection-related sequelae.
SN  - 2452-302X
ER  -